Business
Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above
Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Omnipod 5 is now commercially available in Canada. Omnipod 5 is the first tubeless, waterproof* Automated Insulin Delivery (AID) System approved for use in Canada for people with type 1 diabetes ages two years and above.
About this update from Insulet Corporation
[{"type":"list","items":[{"val":[{"type":"text","content":"New Diabetes Canada Guidelines1 recommend people with type 1 diabetes use an Automated Insulin Delivery System (AID) System for diabetes management","length":157,"tagName":"p"}]},{"val":[{"type":"text","content":"Approximately 300,000 Canadians have type 1 diabetes, with the number of cases growing at an estimated 4.4% per year2","length":117,"tagName":"p"}]},{"val":[{"type":"text","content":"The Omnipod 5 System is designed to be customer-centric and aims to deliver exceptional ease of use. It has demonstrated strong clinical results including lower A1c and improved time in range, while maintaining low time in hypoglycemia3","length":236,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":510,"olType":false},{"type":"text","content":"OAKVILLE, ON, April 7, 2025 /CNW/ - Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Omnipod 5 is now commercially available in Canada. Omnipod 5 is the first tubeless, waterproof* Automated Insulin Delivery (AID) System approved for use in Canada for people with type 1 diabetes ages two years and above.","length":424,"tagName":"p"},{"type":"text","content":"The Omnipod 5 AID System is compatible in Canada with the Dexcom G6 and Dexcom G7 Continuous Glucose Monitoring (CGM) Systems to continuously adapt and automatically deliver insulin according to the user's personal needs, simplifying diabetes for patients. Public reimbursement for Omnipod 5 is currently in place in Ontario and Nova Scotia. Insulet is actively working to expand Omnipod 5 coverage across additional provinces and territories throughout the country.","length":470,"tagName":"p"},{"type":"text","content":""We are thrilled to bring our flagship Omnipod 5 AID System to Canadians," said Janet James, General Manager, Insulet Canada. "This marks a significant step forward to help improve the lives of people living with type 1 diabetes. We have seen first-hand the health and lifestyle benefits Omnipod 5 provides to our users in other countries and are eager to see timely access provided for all Canadians with type 1 diabetes through their provincial health plans."","length":481,"tagName":"p"},{"type":"text","content":"Living with diabetes is very b...